Limburg backs Q Chip and ACS Biomarker.
Limburg Ventures, the Netherlands-based venture capital firm backed by local industrial group DSM and regional development agency LIOF, has backed two companies.
Limburg, Disruptive Capital Finance and Nedermaas Hightech Ventures invested $6m in UK-based drugs maker Q Chip for its series C round. Limburg Ventures has invested in ACS Biomarker, which has also hired Heico Breek as its chief executive.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
